The traditional rehabilitation sector is facing a silent crisis: a growing shortage of therapists combined with an analog approach to recovery that lacks real-time data. While many startups attempt to digitize physical therapy, few manage to cross the “valley of death” between a working prototype and a certified medical device.
Artem Chyhyrynskyi, co-founder of VRNow, is navigating this transition by shifting the focus from local services to a global intellectual property strategy. In an exclusive interview with TechUkraine, he reveals how a Ukrainian team secured a prestigious German patent and why the future of MedTech lies at the intersection of VR and clinical data.
The “Gold Standard” of Trust: The German Patent
For any MedTech startup, entry into the EU market is guarded by rigorous regulatory barriers. VRNow’s recent success in obtaining a German patent isn’t just a legal milestone; it’s a strategic moat.
Validation: The patent confirms the uniqueness of their VR-based neurorehabilitation algorithms.
Investor Confidence: In the VC world, specialized IP in a Tier-1 jurisdiction like Germany significantly de-risks the investment.
Market Entry: This serves as the foundation for their expansion into the DACH region (Germany, Austria, Switzerland), known for its high standards and robust healthcare reimbursement systems.
The Pivot to Deep-Tech Scaling
VRNow isn’t just building software; they are engineering a recovery ecosystem. By utilizing VR headsets to guide patients through neurological and musculoskeletal exercises, the platform provides:
Biofeedback Integration: Real-time monitoring that adjusts difficulty based on patient performance.
Remote Scalability: Allowing one therapist to oversee multiple patients, solving the “human bottleneck” in rehabilitation.
Data-Driven Outcomes: Transitioning from “subjective improvement” to “objective clinical metrics”.
The Global Roadmap
While the war in Ukraine has created an unprecedented need for advanced rehabilitation at home, Chyhyrynskyi is clear: to be sustainable, Ukrainian startups must think globally from Day 1. VRNow is currently optimizing its business model to move beyond hardware-dependence toward a high-margin Software-as-a-Service (SaaS) model, integrated with global medical equipment providers.
Is the Ukrainian MedTech ecosystem ready to become a global hub for clinical innovation? The trajectory of VRNow suggests that the hardware-to-healthcare transition is not just possible—it’s already happening.
Go deeper: For the full strategic breakdown of VRNow’s global expansion and more industry-shaping insights, read the complete exclusive interview available only on the TechUkraine blog.
